Hope you guys enjoy the video! In the video I describe my thoughts on where NVTA is going in terms of price and why I think we could see a large bounce. I use price channels to find structure and typically only trade what I'm charting if price respects the channels. Let me know if you have any questions.
Not sure, just fooling around. What do you guys think?
Invitae Corporation is a medical genetics company. ... The Company offers genetic testing across multiple clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, personalized oncology, metabolic conditions, and rare diseases.
NVTA formed a bullish Butterfly pattern and back in buy zone after closing one day under the SL level.
Seems like a great time to buy, extremes RSI and fairly important historic level. Also some RSI divergance on low time frame
Might be worth watching. This is not investing/financial advice. Do your own due-diligence. Cheers!
At Support Zone Entry 28 Stop 24 Target 43 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology. The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
Back in June 20, NVTA jumped up rather spectacularly and since late Jan 21, bears are beating it down. 24.90 was a critical point but we crashed it down and due to Jun 20 pump up, we are right now in the vacuum between a solid support of 15 and 25. 20 was a resistance in the past, we don`t know whether it will work as a support but my main point is that this gap...
Hello dear padawans. Short and sweet analysis on Invitae: $NVTA on long term support. It is also oversold. Given the lower shadow of current candle investors have strong appetite for current prices On the flip side one could venture reading the long term formation as a head and shoulders pattern. If you are a long term investor, buying here is a no brainer...
$NVTA Target 36.47 for 34.08% Or next add at 25.15 ----- — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. ONLY ADD at support levels & FIB levels… labeled I start every position with .5 - 1% of my account and build from there as needed and as possible. I am...
Chatter over a possible merger of Invitae with Exact Science and it it does, buy the rumours, sell on news. There is a nice double bottom but would want to wait till it surpassed $35/36 before seeing it surging up. Also have to look out to see if NVTA could form a higher highs form and create a solid uptrend. Keep monitoring the price action and watch out for the news!!
$NVTA Target 37.64 for 32.68% Or next add at 26.02 ----- — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. ONLY ADD at support levels & FIB levels… labeled I start every position with .5 - 1% of my account and build from there as needed and as possible. I am...
Possible breakout target around $43. ( one of ARKG stocks) - Buy call option strike $35 , July-16 @ $1 Nvitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W....
$NVTA Target 37.64 for 32.68% Or next add level is at 19.10 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first...
Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. If you want not to miss ideas like this one ,🎯 subscribe and press a...